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1. INTRODUCTION 2. EXPERIMENTAL 
In the cellular slime mold Dictyostelium dis- 
coideum cyclic AMP (CAMP) mediates chemotaxis 
[ 1,2] and differentiation [3,4]. Extracellular CAMP 
is detected by membrane-bound receptors after 
which an adenylate cyclase is transiently activated 
[5]. Part of the newly synthesized CAMP is se- 
creted, part of it probably acts intracellularly. In- 
tracellular CAMP is detected by a high-affinity 
CAMP binding protein, which has a Mr of 40 000 
[6- 121. This protein is present in much higher con- 
centrations in differentiating than in vegetative 
cells [9,12]. 
2.1. D. Discoideum cyclic AMP binding protein 
The 40 K CAMP binding protein is related to the 
regulatory subunits of mammalian protein kinase, 
since it is able to regulate mammalian kinase ac- 
tivity in a CAMP dependent manner [9]. In D. dis- 
coideum a CAMP dependent protein kinase was 
claimed [ 13,141, of which the regulatory subunit 
corresponds to the 40 K CAMP binding protein 
]141. 
D. discoideum cells (strain AX 2) were grown ax- 
enically and starved for 2 h as described earlier 
[ 151. The soluble cell fraction contained only one 
high-affinity CAMP binding protein of 40 000 
daltons as demonstrated by photoaftinity labelling 
([14], U. Walter and R. Van Driel, unpublished). 
Also a low-affinity CAMP binding protein was de- 
tected. The high-affinity binding protein was pu- 
rified about 25 times using Blue Sepharose (Phar- 
macia) [12]. The CAMP binding fractions were 
pooled and dialyzed against binding assay buffer. 
This preparation still contained some of the low- 
affinity binding protein, which did not affect 
CAMP binding data up to 3. lo- 8 M CAMP. The 
total protein concentration was about mg/ml; the 
high-affinity CAMP binding activity was 5 nM. 
2.2. Materials 
In the present paper we describe equilibrium 
and kinetic CAMP binding properties of the 40 K 
protein. The approach of Jastorff et al. [30,31] was 
applied to probe the structure of the CAMP bind- 
ing site using 16 selected CAMP analogues. The 
structure is compared to the D. discoideum cell sur- 
face receptor for CAMP and rabbit muscle CAMP 
dependent protein kinase I. 
* To whom correspondence should be sent. 
[8-3H]cAMP was purchased from Amersham 
Radiochemical Centre (U.K.). ATP, CAMP, 
cGMP, cIMP and compounds 3, 10 and 11 (table 
1) were from Boehringer. All other cyclic nucleo- 
tide derivatives were kindly supplied by Dr B. 
Jastorff, University of Bremen, FRG. MES 
(2-(N-morpholino) ethane sulfonic acid) and 
EGTA (ethyleneglycol-his@-amino ethyl ether) 
N,N,N’,N’-tetraacetic acid) were purchased from 
Sigma. All analogues were checked for the absence 
of CAMP and other impurities by anion-exchange 
HPLC using various mobile phase compositions. 
D. discoideum 
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Table 1 
Binding and activity of CAMP analogues 
No. Analogue CAMP-binding protein CAMP dependent protein 
D. discoideum kinase rabbit-muscle a 
SAG (kJ . mol -I) 6AG (kJ . mol -I) 
CAMP chemotaxis 
receptor 
D. discoideumb 
6AG (kJ . mol -I) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
Adenosine 3’,5’-monophosphate 
Adenosine N-oxide 3’,5’-monophosphate 
6-Chloropurine 3’,5’-monophosphate 
7-Deazaadenosine 3’,5’-monophosphate 
Benzimidazole 3’,5’-monophosphate 
Purine 3’,5’-monophosphate 
Inosine 3’,5’-monophosphate 
Guanosine 3’,5’-monophosphate 
2-Phenyladenosine 3’,5’-monophosphate 
8-Bromoadenosine 3’,5’-monophosphate 
2’-Deoxyadenosine 3’,5’-monophosphate 
3’-Amino-3’-deoxyadenosine 3’,5’-mono- 
phosphate 
5’-Amino-5’-deoxyadenosine-3’,5’-mono- 
phosphate 
Adenosine 3’,5’-monothionophosphate (Sd 
Adenosine 3’,5’-monothionophosphate (Rp) 
Adenosine 3’,5’-monophospho-dimethyl- 
amidate (RP) 
Adenosine 3’,5’-monophospho-dimethyl- 
amidate (Sp) 
0 0 
4.7 6.0 
1.8 1.9 
0.7 3.4 
6.0 4.3 
3.9 6.5 
3.9 8.9 
13.9 13.0 
12.0 7.8 
-2.6 -0.6 
22.0 20.4 
13.0 17.5 26.0 (2 1) 
17.5 18.1 O-6.5 (21) 
4.5 9.6 13.0 (21) 
12.0 16.8 26.0 (21) 
27.3 24.0 26.0 (21) 
17.5 20.3 13.0 * 
0 
6.5 (21) 
19.5 (21) 
13-19.5 (21) 
26.0 * 
26.0 * 
26.0 (22) 
19.5 (22) 
13.0 * 
19.5 (21) 
6.5 (2 1) 
Reported previously [ 191 as determined by competitive binding to isolate regulatory subunits of mammalian protein 
kinase type I. 
Reported previously as determined by chemotactic activity of the cyclic nucleotide derivatives. References are given 
in brackets. 
Unpublished data from Dr Th.M. Konijn. 
6AG is defined in the text. 
2.3. Nucleotide binding assay 
Binding assay buffer composition: 25 mM MES, 
4 mM magnesium acetate, 10 mM sodium phos- 
phate, 0.125 mM EGTA, adjusted with NaOH to 
pH 6.9. For determination of the inhibition con- 
stant (KI) of an analogue, 0.5 nM CAMP binding 
activity was incubated with two [3H]cAMP con- 
centrations (3 and 10 nM) and varying con- 
centrations of unlabeled CAMP or of a derivative. 
Results were plotted according to Dixon [ 161 which 
method allows determination of the KI and dis- 
tinguishes between competitive and non-competi- 
tive inhibition. All analogues were strictly competi- 
tive. Samples were equilibrated at 0°C for at least 
1 h. No degradation of cyclic nucleotides was ob- 
served up to 2 h, as was determined using anion- 
exchange HPLC. Membrane filtration was done as 
reported previously [ 121. 
2.4. Standardization 
In order to compare the KI values of analogues 
for the CAMP-binding protein of D. discoideum to 
results obtained with other proteins and using 
other methods, the following standardization was 
used 
SAG = _ RTln KI (CAMP) 
KI (derivative) 
[17-191 
Thus, the affinity of a derivative relative to CAMP 
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is transformed into the free enthalpy scale. A ten- 
fold increase in the Kt of a derivative corresponds 
to a SAG of 6.5 kJ . mol-‘. 
3. RESULTS 
The binding curve for the partial purified prepa- 
ration was linear up to 3 . lo- * M CAMP with a 
K,j of 2.2 nM (IiglA). At higher concentrations 
binding to a low-affmity component was observed. 
Addition of 0.2 mM ATP had no effect on the 
high-affinity binding for CAMP. Binding to the 
low-affinity component was about two-fold re- 
duced. Association and dissociation velocity mea- 
surements resulted in first order kinetics (fig.lB,C). 
The association rate constant was 8.0. 105 M-‘s-l, 
the dissociation rate constant 1.0. 1O-3 s-1 as mea- 
sured using two methods (dilution of free ligand 
and addition of excess unlabeled CAMP). Above 
results suggest hat in the range up to 3 . lo- 8 M 
LETTERS August 1982 
CAMP, binding to only one type of binding site is 
measured. Calculation of the & from the rate con- 
stants yields 1.3 nM, which is similar to the value 
obtained by measuring at equilibrium. 
Table 1 shows the results of the binding compe- 
tition by 17 analogues of CAMP. None of the ana- 
logues 2-7, altered in the base moiety with respect 
to the potency to form hydrogen bonds, shows a 
significant drop in binding affinity. This indicates 
the absence of hydrogen bond interactions be- 
tween the adenine base and the protein. If the ade- 
nine moiety is recognized and bound by stacking- 
like interactions with an aromatic amino acid side 
chain, the binding affinity of derivatives hould in- 
crease with the polarizing power of the base. 
However, a series of analogues with increasing po- 
larizing power, analogue no. 5 < 6< 1 < 7 < 8 [20] 
shows no increase in binding affinity. 
Derivatives 8 and 9 show a more pronounced 
decrease in affinity, which may be due to steric 
0 4 8 
F XlOl 
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0 40 80 
F&l. (A) Scatchard plot for binding of CAMP to 0.35 nM binding protein. Samples were equilibrated at 0°C for 1 h 
before filtration. (-O-) Binding in the absence of ATP, (-•-) in the presence of 0.2 mM ATP. The arrows indicate free 
CAMP concentrations (F) in mol/l. (B) Dissociation kinetics at 0°C. Samples were equilibrated with 3 . IO- 8 M CAMP 
for 15 min at 0°C. (-•-) At fe 1O-4 M unlabeled CAMP was added and at various times samples were withdrawn and 
filtrated. (-W) At to the incubation mixture was diluted lOO-fold and at various times samples were withdrawn and 
filtrated. The bound radioactivity of all samples was corrected for the residual radioactivity after 1 h of dissociation. 
Bu = bound CAMP at time zero. (C) Association kinetics at 0°C. At 10 3 . lo- 8 M CAMP was added to 0.5 nM CAMP- 
binding protein. At several times samples were taken and filtrated. B, maximal bound CAMP, determined after 10 min 
incubation. 
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Fig.2. Structures of the CAMP derivatives used. Rib-P 
= ribose 3’,5’-monophosphate. Analogue numbers are 
defined in table 1. 
limitations at the 2-position of the base. Analogue 
10 has a higher affinity for the binding protein 
than has CAMP. As this derivative renders the 
CAMP molecule almost totally in the syn-con- 
formation, it is very likely that the cyclic nu- 
cleotide is bound in that conformation. 
In contrast to the adenine base, the ribose 
moiety is bound by at least three hydrogen bonds 
at the positions 2’, 3’ and 5’, as indicated by the 
significant lower affinity of analogues 1 l- 13. In 
compounds 14 and 15 the negative charge of the 
phosphate group is fixed on one of the exocyclic 
oxygen atoms. Compound 15 shows a more pro- 
nounced decrease than 14, which may indicate that 
a salt bridge is formed preferentially with the 
equatorial exocyclic oxygen atom. When no charge 
is present (compound 16,17) the binding affinity is 
still lower, which may also be due to steric effects 
of the bulky dimethylamino group. 
The data in table 1 suggest hat CAMP is bound 
in the same conformation and by the same interac- 
tions as to mammalian protein kinase [ 191. In con- 
trast, binding to the chemoreceptor is of a signifi- 
cantly different type. With this protein CAMP may 
form hydrogen bonds with N-6 and N-7 of the 
base moiety and only with 3’-0 in the ribose. The 
salt bridge may be much alike. Another difference 
is CAMP being bound to the chemotactic receptor 
in the anti-conformation [2 1,221. 
4. DISCUSSION 
In the present report the structure of the CAMP 
binding site of the cytoplasmic CAMP binding pro- 
tein of D. discoideum was probed and compared to 
the ‘stable CAMP binding site’ [27] of mammalian 
protein kinase and the cell surface chemoreceptor 
of D. discoideum. This approach reveals a close re- 
semblance between the positions and interactions 
by which CAMP is bound to the cytoplasmic 40 K 
protein and the ‘stable site’ of rabbit muscle pro- 
tein kinase type I. The binding to the chemotactic 
CAMP receptor is of an entirely different character, 
which may indicate the absence of a structural re- 
lationship. Also the catabolite repressor protein 
(CRP) from Escherichia coli binds CAMP with in- 
teractions different from the 40 K protein. The 
CRP seems to bind CAMP derivatives irrespective 
of the modifications in the base moiety, but the 
cyclic phosphate-ribose rings are specifically re- 
cognized [23,24]. 
Though the binding sites on the 40 K protein 
and mammalian protein kinase are similar, these 
proteins are rather different in several other as- 
pects. The mammalian kinase forms tetramers of 
two catalytic and two regulatory subunits [25]. 
Each regulatory subunit has two non-identical 
CAMP binding sites, being different in dissociation 
kinetics [26-281. In addition CAMP is bound in a 
cooperative way and the binding affinity for 
CAMP is strongly affected by ATP. Binding of 
CAMP to the kinase results in dissociation of the 
catalytic subunits from a regulatory subunit dimer. 
The isolated dimeric regulatory subunits bind 
CAMP to both types of sites in a cooperative way, 
but are unaffected by ATP. In contrast the CAMP 
binding protein of D. discoideum occurs as a 
monomer ([ 1 I] and our unpublished observations) 
and in later differentiation stages as a faster sedi- 
menting complex [ 111. Furthermore, kinetic results 
in this report indicate one type of binding site, 
binding CAMP non-cooperatively and unaffected 
153 
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by ATP. A 37 K tryptic derivative of mammalian 
regulatory subunit was shown to exist in mono- 
meric form, while binding to both CAMP sites was 
normal [29]. It is, however, unlikely that the stud- 
ied 40 K protein is a proteolytic product, since 
various protease inhibitors did not lead to the de- 
tection of a CAMP-binding protein heavier than 
about 40 K [ 12,141. Recently a 42 K regulatory 
subunit of a CAMP dependent protein kinase was 
reported, which may be more related to the 40 K 
protein of D. discoideum [32]. 
The similarity in CAMP binding to the 40 K pro- 
tein and the mammalian protein kinase regulatory 
subunit may suggest a structural relationship, 
which supports previous claims that a functional 
relationship exists, i.e., CAMP-dependent regula- 
tion of protein kinase activity [9,14]. The relatively 
fast dissociation kinetics of the 40 K protein allow 
this protein to respond to the short-term changes 
in CAMP concentration that occur during oscilla- 
tion in D. discoideum [33], whereas the kinetics of 
the mammalian kinase allow response to only long 
term changes. 
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